OUR PEOPLE

BOARD OF DIRECTORS

Our Board of Directors guides our mission with integrity and innovation.

  • Brian Walsh Chairman and CEO Cagent Vascular

    Brian Walsh

    Chairman & CEO
    Cagent Vascular

    LinkedIn →

    Brian Walsh joined Cagent Vascular in 2018 as Chairman of the Board. In 2024, he was appointed to the role of Chief Executive Officer.

    Mr. Walsh served as Head of Carl Zeiss Meditech Cataract Technology from 2018 until 2024. Previously, he was President and CEO of IanTECH Medial, Inc. (acquired by Carl Zeiss Meditech AG) and Transcend Medical, Inc which was acquired by Alcon, formerly a division of Novartis Co (NYSE: NVS).

    He brings over 25 years of medical device and health care industry experience in Marketing, Sales, and Executive Leadership with companies such XTENT Inc., Ventrica Inc., Heartport Inc., Guidant Inc., as well as Devices for Vascular Intervention (DVI), Inc.

  • Casey Tansey General Partner - USVP Cagent Vascular

    Casey Tansey

    General Partner
    USVP

  • Marc-Andre Marcotte, CFA Partner & Head of Venture Capital Cagent Vascular

    Marc-Andre Marcotte, CFA

    Partner & Head
    Venture Capital

  • Jay Brumfield Managing Member — Blue Ridge Medical LLC Cagent Vascular

    Jay Brumfield

    Managing Member
    Blue Ridge Medical, LLC

  • Cagent Vascular Board of Directors member Tak Cheung, Managing Partner & Founder of Astoria Health Investors

    Tak Cheung

    Managing Partner & Founder
    Astoria Health Investors